Újabb ajánlás a molaterhesség befejezését követo hCG-nyomonkövetés eddigi gyakorlatához

Translated title of the contribution: New suggestion to the current practice of hCG follow up after molar evacuation

Jozsef Bátorfi, M. Feltmate Colleen, Iván Szigetvári, József Doszpod, Imre Cseh, S. Berkowitz Ross, V. Fülöp

Research output: Contribution to journalArticle

Abstract

HCG follow up was analyzed from 400 patients treated at New England Trophoblastic Disease Center (NETDC) with either complete or partial hydatidiform mole. Although prolonged serum human chorionic gonadotropin (hCG) monitoring is advised to ensure that relapse is detected, patients may not complete the entire recommended interval of follow up. This study was undertaken to analyze how often patients with molar pregnancy do not complete their entire follow up and to determine the minimal interval of hCG monitoring required for safe screening of relapse. 400 randomly selected patients with molar pregnancy were analyzed regarding the serum hCG levels following molar evacuation. Patients who developed persistent gestational trophoblastic tumor (GTT) before serum hCG had become undetectable were excluded from further analysis (n=67; 17 %). Of the 333 uncomplicated cases, 211 (63 %) completed the recommended hCG follow up protocol. 320 patients achieved at least one negative serum hCG level, and none had any evidence of relapse of persistent GTT. Data indicate that relapse of uncomplicated molar pregnancies is unlikely after undetectable hCG levels are attained. Further follow up may not be indicated.

Original languageHungarian
Pages (from-to)291-295
Number of pages5
JournalMagyar Noorvosok Lapja
Volume66
Issue number5
Publication statusPublished - 2003

Fingerprint

Chorionic Gonadotropin
Hydatidiform Mole
Trophoblastic Neoplasms
Recurrence
Serum
New England

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Bátorfi, J., Feltmate Colleen, M., Szigetvári, I., Doszpod, J., Cseh, I., Berkowitz Ross, S., & Fülöp, V. (2003). Újabb ajánlás a molaterhesség befejezését követo hCG-nyomonkövetés eddigi gyakorlatához. Magyar Noorvosok Lapja, 66(5), 291-295.

Újabb ajánlás a molaterhesség befejezését követo hCG-nyomonkövetés eddigi gyakorlatához. / Bátorfi, Jozsef; Feltmate Colleen, M.; Szigetvári, Iván; Doszpod, József; Cseh, Imre; Berkowitz Ross, S.; Fülöp, V.

In: Magyar Noorvosok Lapja, Vol. 66, No. 5, 2003, p. 291-295.

Research output: Contribution to journalArticle

Bátorfi, J, Feltmate Colleen, M, Szigetvári, I, Doszpod, J, Cseh, I, Berkowitz Ross, S & Fülöp, V 2003, 'Újabb ajánlás a molaterhesség befejezését követo hCG-nyomonkövetés eddigi gyakorlatához', Magyar Noorvosok Lapja, vol. 66, no. 5, pp. 291-295.
Bátorfi J, Feltmate Colleen M, Szigetvári I, Doszpod J, Cseh I, Berkowitz Ross S et al. Újabb ajánlás a molaterhesség befejezését követo hCG-nyomonkövetés eddigi gyakorlatához. Magyar Noorvosok Lapja. 2003;66(5):291-295.
Bátorfi, Jozsef ; Feltmate Colleen, M. ; Szigetvári, Iván ; Doszpod, József ; Cseh, Imre ; Berkowitz Ross, S. ; Fülöp, V. / Újabb ajánlás a molaterhesség befejezését követo hCG-nyomonkövetés eddigi gyakorlatához. In: Magyar Noorvosok Lapja. 2003 ; Vol. 66, No. 5. pp. 291-295.
@article{429b170cf045420491d23ebc800526fe,
title = "{\'U}jabb aj{\'a}nl{\'a}s a molaterhess{\'e}g befejez{\'e}s{\'e}t k{\"o}veto hCG-nyomonk{\"o}vet{\'e}s eddigi gyakorlat{\'a}hoz",
abstract = "HCG follow up was analyzed from 400 patients treated at New England Trophoblastic Disease Center (NETDC) with either complete or partial hydatidiform mole. Although prolonged serum human chorionic gonadotropin (hCG) monitoring is advised to ensure that relapse is detected, patients may not complete the entire recommended interval of follow up. This study was undertaken to analyze how often patients with molar pregnancy do not complete their entire follow up and to determine the minimal interval of hCG monitoring required for safe screening of relapse. 400 randomly selected patients with molar pregnancy were analyzed regarding the serum hCG levels following molar evacuation. Patients who developed persistent gestational trophoblastic tumor (GTT) before serum hCG had become undetectable were excluded from further analysis (n=67; 17 {\%}). Of the 333 uncomplicated cases, 211 (63 {\%}) completed the recommended hCG follow up protocol. 320 patients achieved at least one negative serum hCG level, and none had any evidence of relapse of persistent GTT. Data indicate that relapse of uncomplicated molar pregnancies is unlikely after undetectable hCG levels are attained. Further follow up may not be indicated.",
keywords = "Complete and partial hydatidiform mole, Follow up, Gestational trophoblastic disease, Human chorionic gonadotropin",
author = "Jozsef B{\'a}torfi and {Feltmate Colleen}, M. and Iv{\'a}n Szigetv{\'a}ri and J{\'o}zsef Doszpod and Imre Cseh and {Berkowitz Ross}, S. and V. F{\"u}l{\"o}p",
year = "2003",
language = "Hungarian",
volume = "66",
pages = "291--295",
journal = "Magyar Noorvosok Lapja",
issn = "0025-021X",
publisher = "Magyar Noovos Tarsasag",
number = "5",

}

TY - JOUR

T1 - Újabb ajánlás a molaterhesség befejezését követo hCG-nyomonkövetés eddigi gyakorlatához

AU - Bátorfi, Jozsef

AU - Feltmate Colleen, M.

AU - Szigetvári, Iván

AU - Doszpod, József

AU - Cseh, Imre

AU - Berkowitz Ross, S.

AU - Fülöp, V.

PY - 2003

Y1 - 2003

N2 - HCG follow up was analyzed from 400 patients treated at New England Trophoblastic Disease Center (NETDC) with either complete or partial hydatidiform mole. Although prolonged serum human chorionic gonadotropin (hCG) monitoring is advised to ensure that relapse is detected, patients may not complete the entire recommended interval of follow up. This study was undertaken to analyze how often patients with molar pregnancy do not complete their entire follow up and to determine the minimal interval of hCG monitoring required for safe screening of relapse. 400 randomly selected patients with molar pregnancy were analyzed regarding the serum hCG levels following molar evacuation. Patients who developed persistent gestational trophoblastic tumor (GTT) before serum hCG had become undetectable were excluded from further analysis (n=67; 17 %). Of the 333 uncomplicated cases, 211 (63 %) completed the recommended hCG follow up protocol. 320 patients achieved at least one negative serum hCG level, and none had any evidence of relapse of persistent GTT. Data indicate that relapse of uncomplicated molar pregnancies is unlikely after undetectable hCG levels are attained. Further follow up may not be indicated.

AB - HCG follow up was analyzed from 400 patients treated at New England Trophoblastic Disease Center (NETDC) with either complete or partial hydatidiform mole. Although prolonged serum human chorionic gonadotropin (hCG) monitoring is advised to ensure that relapse is detected, patients may not complete the entire recommended interval of follow up. This study was undertaken to analyze how often patients with molar pregnancy do not complete their entire follow up and to determine the minimal interval of hCG monitoring required for safe screening of relapse. 400 randomly selected patients with molar pregnancy were analyzed regarding the serum hCG levels following molar evacuation. Patients who developed persistent gestational trophoblastic tumor (GTT) before serum hCG had become undetectable were excluded from further analysis (n=67; 17 %). Of the 333 uncomplicated cases, 211 (63 %) completed the recommended hCG follow up protocol. 320 patients achieved at least one negative serum hCG level, and none had any evidence of relapse of persistent GTT. Data indicate that relapse of uncomplicated molar pregnancies is unlikely after undetectable hCG levels are attained. Further follow up may not be indicated.

KW - Complete and partial hydatidiform mole

KW - Follow up

KW - Gestational trophoblastic disease

KW - Human chorionic gonadotropin

UR - http://www.scopus.com/inward/record.url?scp=0141998850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141998850&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0141998850

VL - 66

SP - 291

EP - 295

JO - Magyar Noorvosok Lapja

JF - Magyar Noorvosok Lapja

SN - 0025-021X

IS - 5

ER -